MYASTHENIA-GRAVIS AFTER BONE-MARROW TRANSPLANTATION - EVIDENCE FOR A DONOR ORIGIN

被引：110

作者：

SMITH, CIE

AARLI, JA

BIBERFELD, P

BOLME, P

CHRISTENSSON, B

GAHRTON, G

HAMMARSTROM, L

LEFVERT, AK

LONNQVIST, B

MATELL, G

PIRSKANEN, R

RINGDEN, O

SVANBORG, E

机构：

[1] HUDDINGE UNIV HOSP,BONE MARROW TRANSPLANT UNIT,S-14186 HUDDINGE,SWEDEN

[2] HUDDINGE UNIV HOSP,DEPT MED,DIV CLIN HEMATOL & ONCOL,S-14186 HUDDINGE,SWEDEN

[3] HUDDINGE UNIV HOSP,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN

[4] HUDDINGE UNIV HOSP,DEPT TRANSPLANTAT SURG,S-14186 HUDDINGE,SWEDEN

[5] KAROLINSKA INST,DEPT IMMUNOBIOL,S-10401 STOCKHOLM 60,SWEDEN

[6] UNIV BERGEN,DEPT NEUROL,N-5014 BERGEN,NORWAY

[7] SOUTH HOSP,CTR MYASTHENIA GRAVIS,STOCKHOLM,SWEDEN

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1983年 / 309卷 / 25期

关键词：

D O I：

10.1056/NEJM198312223092508

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1565 / 1568

页数：4

相关论文

共 20 条

[1] THYMOMA-SPECIFIC ANTIBODIES IN SERA FROM PATIENTS WITH MYASTHENIA-GRAVIS DEMONSTRATED BY INDIRECT HEMAGGLUTINATION
AARLI, JA
LEFVERT, AK
TONDER, O
[J]. JOURNAL OF NEUROIMMUNOLOGY, 1981, 1 (04) : 421 - 427
[2] BODMER WF, 1977, HISTOCOMPATIBILITY T
[3] CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89
[4] INFECTIOUS - MYASTHENIA
DATTA, SK
SCHWARTZ, RS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (24) : 1304 - 1305
[5] GROB D, 1981, ANN NY ACAD SCI, V377, P1
[6] Kissmeyer-Nielsen F., 1967, HISTOCOMPATIBILITY T, P381
[7] DETERMINATION OF ACETYLCHOLINE-RECEPTOR ANTIBODY IN MYASTHENIA-GRAVIS - CLINICAL USEFULNESS AND PATHOGENETIC IMPLICATIONS
LEFVERT, AK
BERGSTROM, K
MATELL, G
OSTERMAN, PO
PIRSKANEN, R
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1978, 41 (05) : 394 - 403
[8] DIFFERENCES IN THE INTERACTION OF ACETYLCHOLINE-RECEPTOR ANTIBODIES WITH RECEPTOR FROM NORMAL, DENERVATED AND MYASTHENIC HUMAN-MUSCLE
LEFVERT, AK
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1982, 45 (01) : 70 - 73
[9] MINCHINTON RM, 1982, LANCET, V2, P627
[10] NAKAO Y, 1980, LANCET, V1, P677